Previous studies have shown that under certain conditions some thiol-containing compounds can cause apoptosis in a number of different cell lines. Herein, we investigated the apoptotic pathways in HL-60 cells triggered by dithiothreitol (DTT), used as a model thiol compound, and tested the hypothesis that thiols cause apoptosis via production of hydrogen peroxide (H 2 O 2 ) during thiol oxidation. The results show that, unlike H 2 O 2 , DTT does not induce apoptosis via a mitochondrialpathway.Thisisdemonstratedbytheabsenceof early cytochromec release from mitochondriainto the cytosol, the lack of mitochondrial membrane depolarization at early times, and the minor role of caspase 9 in DTT-induced apoptosis. The first caspase activity detectable in DTT-treated cells is caspase 3, which is increased significantly 1 ± 2 h after the start of DTT treatment. This was shown by following the cleavage of both a natural substrate, DFF-45/ICAD, and a synthetic fluorescent substrate, z-DEVD-AFC. Cleavage of substrates of caspases 2 and 8, known as initiator caspases, doesnotstartuntil3 ± 4 hafterDTTexposure,wellaftercaspase 3 has become active and at a time when apoptosis is in late stages, as shown by the occurrence of DNA fragmentation to oligonucleosomal-sized pieces. Although oxidizing DTT can produce H 2 O 2 , data presented here indicate that DTT-induced apoptosisisnotmediatedbyproductionofH 2 O 2 andoccursvia a novel pathway that involves activation of caspase 3 at early stages, prior to activation of the common`initiator' caspases 2, 8 and 9.
Introduction
Thiol-containing compounds are effective radiation protectors and anti-oxidants that decrease cell injury from various oxidative stresses. In contrast to that protective effect, we and others have shown that, under certain circumstances, thiols can cause apoptosis. Our initial studies demonstrated that thiols such as dithiothreitol, cysteine, cysteamine, lipoic acid and WR-1065 cause apoptosis in HL-60 human promyelocytic leukemia cells in a fashion dependent on drug concentration and exposure time. 1 Studies by others have shown that some of the same thiols, i.e., cysteine, cysteamine and WR-1065, cause apoptosis in mouse hybridoma TB8.3 cells 2 and that N-acetylcysteine (NAC) causes apoptosis in mouse embryo fibroblasts, but only if the cells are transformed and express wild-type p53. 3 However, little is known about the pathways involved in thiol-induced apoptosis.
Two general, major pathways for apoptosis have been identified, both requiring active caspase proteins either in the early steps (initiator caspases) or in the later stages (effector caspases) of apoptosis. 4 ± 6 Caspases are present in cells as inactive zymogens that are activated via action of other proteases, including caspases, into heterotetramers formed from two large and two small subunits. One of the apoptotic pathways is induced through death receptors (such as Fas/CD95, TNFa) which directly activate caspases 8/10 and subsequently trigger caspase executioners (activation of caspases 1/4/5 and then caspases 3/6/7) and cell death. In this pathway, mitochondrial signaling seems to be unnecessary but may contribute to apoptosis at a later time as an amplification mechanism. 7 ± 11 The second general apoptotic pathway is induced by a variety of stimuli including chemotherapeutic drugs, ionizing radiation, etc. In this case, apoptosis occurs through a mitochondria-dependent mechanism in which one of the key hallmarks is the release into the cytosol of apoptotic activating factors such as cytochrome c and AIF, Apoptosis Inducing Factor. 4,5,12 ± 17 Studies with cell free systems have shown the ability of cytosolic cytochrome c, in interaction with the Apaf-1 and dATP, to process the central initiator caspase 9, then the downstream execu-tioners such as caspases 3, 6 and 7. 18 ± 21 In some instances the death receptor/caspase 8 pathway and the mitochondria/caspase 9 pathway seem to be separate pathways until they converge at caspase 3. However, in other instances there can be crosstalk between the caspase 8 and caspase 9 pathways, e.g., caspase 8 can activate caspase 9 via BID cleavage, 8 or feedback amplification loops, e.g., caspase 3 can activate caspase 9. 22 Activated caspases lead to the proteolysis of a number of cellular substrates (including PARP, DNA-PK, lamins, and DFF-45/ICAD). 23 At least one endonuclease, the CAD/ DFF-40 (Caspase Activated DNase), is known to be activated directly by the caspase pathway. 24 Thiols are able to act as antioxidants by reacting with reactive oxygen species (ROS: hydrogen peroxide,
. OH, etc.) at relatively high drug concentrations. However, thiols also can be pro-oxidants producing ROS in vitro, particularly H 2 O 2 via copper-catalyzed thiol oxidation and . OH via the Fenton reaction. 25, 26 Several studies have suggested involvement of hydrogen peroxide in thiolinduced cell death in attached cell lines, 1,27 ± 30 although the role of ROS in thiol-induced apoptosis has not been investigated.
Hence, the goals of the present study are twofold. The first is to investigate the apoptotic pathway(s) triggered by thiols in HL-60 cells by assessing the involvement of specific caspases and mitochondria. Potential mitochondrial involvement is of particular interest because mitochondria have been implicated in apoptosis induction by numerous stimuli, especially oxidants. 31, 32 The second goal is to compare thiol-induced apoptosis with that induced by H 2 O 2 and determine whether thiols cause apoptosis through production of H 2 O 2 . In these studies we have used the dithiol DTT as a model compound because our previous work has shown that it yields similar results to those obtained using cysteine, cysteamine, lipoic acid and WR1065, yet it is somewhat easier to use because of its slower oxidation rate. 1, 29 Human leukemia HL-60 cells are used in these studies because they are sensitive to a large panel of apoptotic stimuli including anticancer drugs such as etoposide and camptothecin and pro-oxidant agents such as hydrogen peroxide. 33, 34 Results Apoptotic DNA fragmentation is induced by both DTT and H 2 O 2 but on different time scales
Exposure of HL-60 cells to DTT or H 2 O 2 led to a timedependent apoptotic cell death as determined by the DNA fragmentation assay ( Figure 1A ). The 2 mM DTT concentration was used in these experiments as it induces the highest apoptosis level in this cell line (Tartier et al, in preparation). Apoptotic DNA ladders are visualized on agarose gels with ethidium bromide (Figure 1B,C) . DNA fragmentation was increased substantially after 2 h and was maximum at 4 ± 5 h after treatment with H 2 O 2 (100 mM). With DTT (2 mM), DNA fragmentation starts at 2 ± 3 h and is maximum at 5 ± 6 h after the start of DTT exposure. Hence, DTT-induced apoptosis is delayed 1 ± 2 h relative to that caused by H 2 O 2 . The DNA fragmentation is caused by the reduced form of DTT as treatment with oxidized DTT does not induce DNA fragmentation (data not shown).
DTT-treated cells show a low but prolonged production of intracellular hydrogen peroxide DCFH-DA passively diffuses through cell membranes, where the acetate is cleaved off by intracellular esterases to form DCFH. DCFH is commonly used to detect the generation of reactive oxygen intermediates. 35, 36 Results shown in Figure 2A indicate that cells treated with 2 mM DTT start to show generation of ROS within 5 min of the addition of the drug, the ROS generation appears maximal at 15 min, then generation decreases to control, untreated levels by 2 h. By comparison, cells treated with H 2 O 2 show the maximal DCF fluorescence at the earliest measurable time point, then detectable ROS decrease with time to reach control levels in about 1 h ( Figure 2B ). Also, although the H 2 O 2 -treated cells reach the same maximal ROS levels as menadione treated cells, the DTT-treated cells never reach that maximal level of ROS. These data suggest DTT produces ROS in a slower fashion than occurs when a bolus of H 2 O 2 is added to cells, and are consistent with our earlier data showing that the half-life for DTT oxidation (i.e., production of H 2 O 2 ) is about 1.3 h in medium 29 and slightly less than an hour in the presence of cells (Held et al, unpublished (Figure 2A) , the H 2 O 2 is not responsible for the DTT-induced apoptosis.
Activation of caspase 3 is required for DTT-induced apoptosis
Processing of the so-called`executioner' caspase 3 protein into its active form and subsequent cleavage of various substrates by the active caspase 3 is associated with apoptosis induced by a broad range of agents. 6, 7, 10 Therefore, both caspase processing and caspase activity were measured in DTT-treated cells, the former by Western blot analysis of procaspase cleavage and the later by testing the ability of caspases to cleave natural or synthetic fluorescent peptide substrates.
Caspase 3 cleavage into 19-and 17-kDa products is evident after 2 h DTT-treatment ( Figure 3A ). The 17-and 11-kDa fragments (the latter not recognized by the antibody used) are the active subunits of caspase 3. 10, 15, 38, 39 The ability of activated caspase 3 to cleave a natural substrate, DFF-45/ICAD ( Figure 3B ), and the specific synthetic substrate, z-DEVD-AFC ( Figure 3C ), are also shown. Cleavage of both substrates was detectable 1 ± 2 h after the start of DTT-treatment, and maximum activity with the fluorescent substrate, about 0.7 nmoles AFC cleaved/h/10 6 cells, was reached at 4 ± 5 h ( Figure  3C ). Cleavage of the natural substrate DFF-45/ICAD is specific for caspase 3-like activity as the addition of z-DEVD-cmk, an irreversible inhibitor of caspase 3, prevents its cleavage ( Figure 3B ). Once cleaved, DFF-45/ICAD releases the protein DFF-40, also known as Caspase Activated DNase (CAD), which is responsible for at least part of the apoptotic DNA fragmentation, 24 such as that seen in Figure 1 .
40,41
Caspases 2, 8, 9 and 1 play minor roles, if any, in DTT-induced apoptosis Generally, caspase 3 must be processed by other caspases or proteases in order to be activated. Therefore, we next investigated the possible involvement in thiolinduced apoptosis of caspases 2, 8, 9 and 1/4, all of which are known to activate caspase 3 in other circumstances. 6, 15 The effects of irreversible cell permeable caspase inhibitors were studied first. z-DEVD-cmk, z-LEHD-fmk and Ac-YVAD-cmk, inhibitors of caspases 3, 9 and 1/4, respectively, were tested, as well as the pancaspase inhibitor z-VAD-fmk ( Figure 4 ). DTT-induced DNA fragmentation is decreased significantly by z-VAD-fmk (3.5-fold decrease at 50 mM; total inhibition with 100 mM ± data not shown), but is decreased only partially by z-DEVD-cmk (twofold decrease at 200 mM). This is consistent with a partial decrease of PARP cleavage by z-DEVD-cmk (data not shown). On the other hand, z-DEVD-cmk prevents cleavage of DFF-45 ( Figure 3B ). z-VAD-fmk also completely prevents DFF-45 cleavage, but only partially prevents cleavage of PARP (data not shown). The data in Figure 4A , showing only partial protection by z-DEVDcmk, together with the PARP cleavage observations, suggest that a protease in addition to caspase 3 is involved in the thiol-induced pathway. The inhibitors Ac-YVAD-cmk and z-LEHD-fmk fail to inhibit DNA fragmentation induced by DTT-treatment, indicating caspases 1/4 and 9 are not involved in this pathway. However, a low cleavage activity of caspase 9 toward its synthetic substrate was observed ( Figure 3C ). The cleavage started 4 h after treatment and reached maximum activity (about 0.1 nmoles AFC/h/10 6 cells) after 5 h. In contrast to the significant protection against DTTinduced apoptosis afforded by z-DEVD-cmk ( Figure 4A ), this caspase 3 inhibitor has no effect on H 2 O 2 -induced apoptosis ( Figure 4B ). Furthermore, although the caspase 9 inhibitor z-LEHD-fmk has no effect on DTTinduced apoptosis, it decreases H 2 O 2 -induced apoptosis about 25% ( Figure 4B ). These observations suggest that, at least in part, the relative importance of different caspases varies for apoptosis induced by DTT and H 2 O 2 .
The roles of caspases 2 and 8 were assessed by observing the cleavage kinetics of their synthetic substrates ( Figure 3C ). Activity of both caspases increases 3 ± 4 h after the start of DTT treatment with a maximum activity reached at 5 h (about 0.2 nmoles AFC/h/10 6 cells). Thus, this increase occurs later than the increase in caspase 3 activity. For caspase 8, this late activation was confirmed by Western blot, which shows that a significant cleavage of procaspase 8 is seen only after 4 and 6 h DTT-treatment Figure 5A ), well after the activation of caspase 3. The addition of z-DEVD-cmk, an inhibitor selective for caspase 3, to DTT-treated cells causes a significant decrease of procaspase 8 cleavage ( Figure 5B ). This finding, together with the slow and small activation of caspase 8 compared with caspase 3 ( Figure 3C ), suggests caspase 8 is activated downstream of caspase 3. In summary, the data suggest caspases 2, 8, 9 and 1/4 are not good candidates to be upstream of caspase 3, but they are activated later in the thiol-induced apoptotic process as part of a feedback loop to amplify the apoptosis signal. This activation occurs at a time when cells are already undergoing extensive DNA fragmentation ( Figure 1A ).
DTT-induced apoptosis does not involve mitochondrial signaling
The opening of the mitochondrial permeability transition (PT) pore appears to be a common event in apoptosis induced by several stimuli triggering oxidative stress, e.g., hydrogen peroxide or t-butylhydroperoxide. 32, 42 It has been shown that when PT is happening, the opening of the pores and the subsequent collapse of the mitochondrial trans-membrane potential (DC m ) constitute an irreversible step leading to apoptosis. 43 ± 45 Mitochondrial cytochrome c release may also occur and can either precede the drop in DC m 12,13,20 or occur concomitant with the PT pore opening. 46, 47 With DTT treatment, there is a slight and slow decrease of the DC m (Figure 6 ), which follows approximately the same time course as that seen for apoptotic DNA fragmentation in this cell line, starting at 3 h and reaching a maximum 6 h after treatment ( Figure 1A) . In contrast, the mitochondrial uncoupler mClCCP causes a rapid decrease in DC m to low levels. The small decrease in DC m caused by DTT may only reflect non-specific changes in mitochondria at relatively late times in the apoptotic pathway. Such an assumption is confirmed by adding cyclosporin A (a ligand of cyclophilin D that is a constituent of the PT pore known for inhibiting its opening), 15, 48, 49 to DTT treated-cells. Cyclosporin A has no effect on the slow decrease of DC m induced by DTT ( Figure 6 ).
Cytochrome c level was also analyzed by Western blot in both cytosolic and mitochondrial fractions of DTT or cytosolic fraction, indicating there was negligible mitochondrial contamination in the preparations. As cytosolic cytochrome c is indispensible for caspase 9 activation, 15 ,21 the late and small cytosolic increase observed here is in accordance with the late activation of caspase 9 seen in the study of cleavage of its fluorescent substrate in DTT-treated cells ( Figure 3C ). The data imply that mitochondrial signaling does not have a major role in DTT-induced apoptosis, but seems rather to contribute at a later time, perhaps as part of an amplification mechanism. However, the H 2 O 2 results show that HL-60 cells activate the cytochrome c pathway to apoptosis early in response to at least some stimuli.
Discussion
Caspase proteins with long prodomains allow caspase aggregation and subsequent autocatalytic activation (such as caspase 2, 8, 10, 1/4 and 9), and are commonly believed to act in initial steps of apoptosis. Caspases with short prodomains (such as caspase 3, 6 and 7) commonly act as executioner caspases. 6, 7, 22, 50 The sequential caspase processing appears to be strongly cell type-and stimulusdependent, although caspase 3 is generally activated late in most systems studied. Strikingly, our data with DTT treatment of HL-60 cells show caspases 2, 8 and 9, usually initiator caspases, are activated later than caspase 3. Figure 5B , which shows that a caspase 3 inhibitor can prevent procaspase 8 activation, emphasizes this result. Additionally, data presented here show that the DTT-induced apoptosis pathway is independent of mitochondrial signaling: there are no early changes in either cytosolic cytochrome c levels or the DC m (Figures 6 and 7A) , and the inability of a caspase 9 inhibitor to inhibit DTT-induced apoptosis ( Figure  4A ) indicates caspase 9 does not have a key role in this pathway. Thus caspase 3 appears to be an initiator caspase in DTT-treated HL-60 cells, with caspases 2, 8 and 9 activated late and only in a feedback loop, probably due to cleavage by the activated caspase 3. There are other literature reports describing the ability of caspase 3 to cleave, in vitro and in vivo, upstream caspases, such as caspase 9, as part of a feedback apoptosis amplification loop. 15, 23, 51, 52 Although caspase 3 seems to be an initiator rather than an executioner caspase in thiol-treated HL-60 cells, the identity of the initial event triggering procaspase 3 processing is unclear. Studies from Suzuki et al 38 . Such a pathway could possibly be involved here, but we have been unable to test this hypothesis as all commonly-used serine protease inhibitors we have tested to date, e.g., TPCK and TLCK, cause rapid necrosis (total cell lysis within 1 h) in HL-60 cells or have no effect on thiolinduced apoptosis at the very low doses where they do not cause cell killing (data not shown). Other approaches to test for a potential role of serine proteases in this system are being investigated. Alternatively, since the caspase 3 inhibitor is unable to inhibit DTT-induced apoptosis totally, although the pan-caspase inhibitor does ( Figure 4A ), other as yet unidentified caspases may be involved in DTT-induced activation of caspase 3. A number of instances have been reported in the literature of thiol-containing compounds protecting against apoptosis induced, for example, by ionizing radiation, 2, 53, 54 etoposide 55 and TNF-a. 56 In those studies, the thiols were used under controlled conditions where cell killing by the thiols was minimal. On the other hand, our earlier data, 1 as well as the data reported herein, have shown clearly, that thiols can cause apoptosis in HL-60 cells. Other examples of thiol-induced apoptosis or thiol enhancement of 2,3,57 The paper by Liu et al 3 is particularly interesting. They demonstrated that NAC-induced apoptosis in mouse embryo fibroblasts (MEFs) occurred only if the cells were transformed and wild-type p53; non-transformed MEFs or transformed, p53 null MEFs did not undergo apoptosis when treated with NAC. Those data are consistent with our observations that NAC does not cause apoptosis in HL-60 cells 1 that are neoplastically transformed and functionally p53 null. On the other hand, in HL-60 cells NAC is not typical of many thiols such as WR-1065, cysteamine, cysteine and lipoic acid that cause apoptosis in a fashion analogous to that shown in this study with DTT 1 (Held et al,  unpublished data) . Clearly, the mode of thiol-induced apoptosis depends on both the specific thiol and the cell type. Hence, it is important to elucidate these various actions when thiols are used as anti-oxidants and antiapoptosis agents.
In previous studies with DTT and other thiols, we had shown that hydrogen peroxide produced by coppercatalyzed thiol oxidation was involved in thiol-induced cell killing measured as loss of clonogenic ability in attached cell lines. 1, 29, 30, 58 Hence, the original postulate in the current work was that thiol-induced apoptosis in HL-60 cells would also be mediated by hydrogen peroxide production. Data presented in this paper show that hydrogen peroxide is effective in causing apoptosis in HL-60 cells (Figure 1) , consistent with data of others, 59 and that DTT can produce hydrogen peroxide in cells ( Figure  2A ). However, three sets of new data in this paper do not support the hypothesis that DTT-induced apoptosis is mediated by hydrogen peroxide production. First, pyruvate and catalase, which effectively remove hydrogen peroxide, 35 do not protect against DTT-induced apoptosis (Table  1) . Second, Figure 4 shows that the patterns of protection by caspase inhibitors are, at least in part, different for DTTand H 2 O 2 -induced apoptosis. Third, Figure 7 shows that treating HL-60 cells with hydrogen peroxide causes rapid release of cytochrome c from mitochondria into the cytosol, although treating the cells with DTT did not cause any changes in cytochrome c. Hence, alternative, non-hydrogen peroxide mediated, mechanisms for activation of apoptosis by thiols in HL-60 cells need to be considered. One potential mechanism is a thiol-mediated reduction of critical disulfides in an enzyme(s) involved in the apoptosis pathway, e.g., a protease that cleaves caspase 3 to its active form. It is unlikely that DTT acts directly on caspase 3 because DTT is commonly included in the reaction buffer used in caspase activity assays and does not cause any activation itself ( Figure 3C ). Clearly, whole cells are required for the initiation of the apoptosis process by DTT. Alternatively, the thiol could be chelating zinc and thus preventing the apoptosis-inhibiting actions of zinccontaining IAP (inhibitor of apoptosis) proteins. 60 In conclusion, we have demonstrated a novel pathway to apoptosis caused by thiols in HL-60 cells in which caspase 3, usually a downstream or`effector' caspase, is activated early, and neither of the common upstream pathways via mitochondria/caspase 9 or death receptor/caspase 8 are involved until the late stages of apoptosis, when DNA fragmentation is well advanced. Although DTT can produce H 2 O 2 , DTT does not appear to be acting via an H 2 O 2 -mediated pathway to cause apoptosis. 
Materials and Methods

Cell culture
Human leukemia HL-60 cells were cultured in RPMI 1640 medium supplemented with penicillin (100 mg/ml), streptomycin (100 units/ml) and 20% fetal bovine serum (FBS). The cells were maintain in log phase growth at 378C under a humidified atmosphere of 5% CO 2 .
Agarose gel electrophoresis of DNA DNA samples were prepared for agarose gel electrophoresis following the procedure of Hopcia et al. 61 DNA fragments were visualized by ethidium bromide staining.
Flow cytometry analysis of cells by DCFH-DA staining
In order to determine the presence of intracellular oxidants, HL-60 cells were treated in complete medium at 378C with 2 mM DTT or 100 mM H 2 O 2 for various times. As a positive control, cells were treated with 1 mM menadione for 15 min. DCFH-DA (10 mM) was added 30 min prior to analysis by flow cytometry (Epics-Elite flow cytometer). A total of 10 000 events were analyzed for each sample. Data were analyzed using CellQuest software and are representative of three replicate experiments.
Western blotting for caspases and DFF-45
Control and treated cells were lysed in lysis buffer (10 mM HEPES pH 7.4, 42 mM KCl, 5 mM MgCl 2 , 0.1 mM EDTA, 0.1 mM EGTA, 5 mM DTT, 2 mM PMSF, 16complete protease inhibitor cocktail) containing 0.5% CHAPS. Cellular debris were spun down at 14 0006g for 20 min, and the supernatants were used as whole cell protein extracts. Polyclonal Ab anti-caspase 3 (antiserum, Pharmingen, San Diego, CA, USA) was diluted at 1 : 2000, anti-caspase 8 (clone B9-2, Pharmingen) at 1 mg/ml and polyclonal anti-DFF-45 (C-19, Santa Cruz Biotech) at 1 : 1000. The appropriate horseradish peroxidase coupled secondary antibody was used, and bound antibodies were revealed with ECL-Plus (Amersham, Arlington, IL, USA).
Preparation of cytosolic and mitochondrial extract for cytochrome c immunoblotting
Cytosolic and mitochondrial fractions were obtained as described by Han et al. 17 Thirty mg of cytosolic protein extract or 10 mg of 
Caspase assay
Caspase activities were assayed by release of AFC-fluorescent compound from synthetic peptides according to the procedures of the kit manufacturer (Clontech). Approximately 1610 6 cells were spun at 2000 r.p.m. for 5 min, washed in PBS, and resuspended in 50 ml of chilled cell lysis buffer. The cell lysates were centrifuged at 12 000 r.p.m. for 3 min, the supernatants were transferred to new tubes, and 50 ml of 26reaction buffer [100 mM HEPES pH 7.2, 0.2 M NaCl, 2 mM EDTA, 0.2% CHAPS, 20% sucrose] containing 5 mM DTT was added. The reactions were initiated by addition of 50 mM substrates-AFC and incubated 1 h at 378C. The fluorescence was read on a Perkin-Elmer LS-5 fluorometer with excitation and emission wavelengths of 400 nm and 505 nm, respectively.
DNA fragmentation assay for apoptosis
DNA fragmentation characteristic of apoptosis was measured according to the method of Sellins and Cohen, 62 with modification. 61 Cellular DNA was labeled by growth of cells in medium containing 0.02 mCi/ml [ 14 C]-thymidine for approximately 24 h, followed by a`chase' in fresh medium lacking radiolabel for 4 h before drug treatments. After treatment, cells at a concentration of about 5610 5 cells/sample were lysed (10 mM Tris, 1 mM EDTA and 0.2% Triton X-100, pH 7.5). The cell lysates were centrifuged at 13 0006g for 10 min at 48C, and the DNA of the separated pellet and supernatant was hydrolyzed for 20 min at 908C by the addition of HCl to a final concentration of 1 N. The samples were mixed with scintillation cocktail (Scintiverse II, Fisher Scientific) and counted in a Packard Tri Carb 4000 series liquid scintillation counter. The percentage of fragmented DNA in each sample was calculated as the amount of DNA in the supernatant divided by the total DNA for that sample (supernatant plus pellet).
Assessment of mitochondrial potential
Mitochondrial trans-membrane potential (DC m ) was evaluated using DiOC 6 (3), a fluorochrome which incorporates into cells dependent upon their DC m . Cells (at about 5610 5 /ml) were pre-incubated with 60 nM DiOC6(3) for 30 min at 378C in the dark, then washed once in media and drug added. At appropriate times after drug addition, cells were washed and resuspended in PBS. The fluorescence was measured in PBS on a Perkin-Elmer LS-5 spectrofluorometer (excitation 487 nm, emission 515 nm). Control experiments were performed in the presence of 100 mM mClCCP, an uncoupling agent that abolishes the DC m .
